[HTML][HTML] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
MD Galsky, S Daneshmand, S Izadmehr… - Nature medicine, 2023 - nature.com
Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
MD Galsky, S Daneshmand, S Izadmehr… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
MD Galsky, S Daneshmand, S Izadmehr… - Nature …, 2023 - ohsu.elsevierpure.com
Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
MD Galsky, S Daneshmand, S Izadmehr… - Nature …, 2023 - europepmc.org
Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
[HTML][HTML] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
MD Galsky, S Daneshmand, S Izadmehr… - Nature …, 2023 - ncbi.nlm.nih.gov
Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
MD Galsky, S Daneshmand, S Izadmehr… - Nature …, 2023 - europepmc.org
Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …
altering. We initiated a phase 2 study in which patients with MIBC received four cycles of …